Richard J. Jones

5.6k total citations · 2 hit papers
116 papers, 4.1k citations indexed

About

Richard J. Jones is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Richard J. Jones has authored 116 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 34 papers in Hematology and 22 papers in Oncology. Recurrent topics in Richard J. Jones's work include Multiple Myeloma Research and Treatments (14 papers), Ubiquitin and proteasome pathways (13 papers) and Hematopoietic Stem Cell Transplantation (12 papers). Richard J. Jones is often cited by papers focused on Multiple Myeloma Research and Treatments (14 papers), Ubiquitin and proteasome pathways (13 papers) and Hematopoietic Stem Cell Transplantation (12 papers). Richard J. Jones collaborates with scholars based in United States, United Kingdom and China. Richard J. Jones's co-authors include P.V. Kolinsky, D. Bloor, Georgia B. Vogelsang, Rein Saral, George W. Santos, Victor G. Vogel, Louise B. Grochow, Hayden G. Braine, William E. Beschorner and Seth R. Marder and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Richard J. Jones

113 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATION

1987 673 citations Richard J. Jones, William E. Beschorner et al. Transplantation profile →
Heart Disease: A Textbook of Cardiovascular Medicine

1988 438 citations Richard J. Jones profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard J. Jones United States	30	1.2k	957	821	617	606	116	4.1k
Matthias Pfeiffer Germany	37	1.0k 0.9×	864 0.9×	635 0.8×	360 0.6×	48 0.1×	142	4.3k
William P. Petros United States	29	1.3k 1.1×	309 0.3×	1.2k 1.5×	201 0.3×	105 0.2×	96	3.7k
Irwin H. Krakoff United States	32	1.5k 1.3×	388 0.4×	1.7k 2.0×	529 0.9×	228 0.4×	124	4.5k
Robert C. Brasch United States	49	1.0k 0.9×	116 0.1×	354 0.4×	539 0.9×	283 0.5×	218	7.5k
Marcel Rozencweig Belgium	30	998 0.9×	317 0.3×	1.9k 2.3×	393 0.6×	591 1.0×	151	4.0k
Soma Das India	35	1.3k 1.1×	192 0.2×	507 0.6×	134 0.2×	222 0.4×	113	3.7k
Giuseppe Toffoli Italy	46	3.9k 3.3×	319 0.3×	3.1k 3.8×	549 0.9×	153 0.3×	337	8.8k
Dana R. Abendschein United States	40	1.4k 1.2×	746 0.8×	153 0.2×	850 1.4×	1.9k 3.2×	127	5.5k
James T. Cassidy United States	40	1.6k 1.4×	1.2k 1.2×	2.9k 3.5×	804 1.3×	239 0.4×	106	7.2k
Chang W. Song United States	42	2.0k 1.7×	199 0.2×	868 1.1×	476 0.8×	84 0.1×	171	6.5k

Countries citing papers authored by Richard J. Jones

Since Specialization

Citations

This map shows the geographic impact of Richard J. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard J. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard J. Jones more than expected).

Fields of papers citing papers by Richard J. Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard J. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard J. Jones. The network helps show where Richard J. Jones may publish in the future.

Co-authorship network of co-authors of Richard J. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Richard J. Jones. A scholar is included among the top collaborators of Richard J. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard J. Jones. Richard J. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

DeZern, Amy E., Marianna Zahurak, Kenneth R. Cooke, Richard J. Jones, & Robert A. Brodsky. (2022). Alternative Bone Marrow Transplantation with Post-Transplant Cyclophosphamide (PTCy) As Initial Therapy for Acquired Severe Aplastic Anemia (SAA). Blood. 140(Supplement 1). 4868–4869. 1 indexed citations

DeZern, Amy E., et al.. (2021). The Art of Donor Selection: Donor Age and Relationship in NMA Haplo BMT. Transplantation and Cellular Therapy. 27(3). S240–S240. 1 indexed citations

Zhuang, Junling, Fazal Shirazi, Ramesh Singh, et al.. (2019). Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma. Blood. 133(14). 1572–1584. 57 indexed citations

Shirazi, Fazal, Veerabhadran Baladandayuthapani, Heather Lin, et al.. (2018). Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191. Clinical Cancer Research. 24(24). 6408–6420. 14 indexed citations

Jones, Richard J., Tawin Iempridee, Xiaobin Wang, et al.. (2016). Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein–Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros Expression. Clinical Cancer Research. 22(19). 4901–4912. 39 indexed citations

Zhuang, Junling, Hans C. Lee, Isere Kuiatse, et al.. (2016). The Anti-Tumor Effect of the Ubiquitin-Activating Enzyme (UAE) Inhibitor TAK-243 on Pre-Clinical Models of Multiple Myeloma. Blood. 128(22). 3296–3296. 4 indexed citations

Kuiatse, Isere, Veerabhadran Baladandayuthapani, Heather Lin, et al.. (2015). Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenström Macroglobulinemia. Clinical Cancer Research. 21(11). 2538–2545. 16 indexed citations

Sharkis, Saul J., Richard J. Jones, Curt I. Civin, & Yoon-Young Jang. (2012). Pluripotent Stem Cell–Based Cancer Therapy: Promise and Challenges. Science Translational Medicine. 4(127). 127ps9–127ps9. 48 indexed citations

Ryan, Julie L., Richard J. Jones, Shannon C. Kenney, et al.. (2010). Epstein-Barr virus-specific methylation of human genes in gastric cancer cells. Infectious Agents and Cancer. 5(1). 27–27. 50 indexed citations

10.

Karp, Judith E., Amanda L. Blackford, B. Douglas Smith, et al.. (2009). Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia. Leukemia Research. 34(7). 877–882. 54 indexed citations

11.

Ryan, Julie L., Richard J. Jones, Sandra Elmore, et al.. (2009). Epstein-Barr Virus <i>WZhet</i> DNA Can Induce Lytic Replication in Epithelial Cells in vitro, although <i>WZhet</i> Is Not Detectable in Many Human Tissues in vivo. Intervirology. 52(1). 8–16. 5 indexed citations

12.

Jones, Richard J., Qing Chen, Peter M. Voorhees, et al.. (2008). Inhibition of the p53 E3 Ligase HDM-2 Induces Apoptosis and DNA Damage–Independent p53 Phosphorylation in Mantle Cell Lymphoma. Clinical Cancer Research. 14(17). 5416–5425. 27 indexed citations

13.

Krishnan, Chitra, Adam Kaplin, Robert A. Brodsky, et al.. (2008). Reduction of Disease Activity and Disability With High-Dose Cyclophosphamide in Patients With Aggressive Multiple Sclerosis. Archives of Neurology. 65(8). 1044–51. 65 indexed citations

14.

Hess, Allan D., Richard J. Jones, Lawrence E. Morris, et al.. (1992). Autologous graft-versus-host disease: A novel approach for antitumor immunotherapy. Human Immunology. 34(3). 219–224. 23 indexed citations

15.

Girling, I.R., R. T. Stewart, Graham H. Cross, et al.. (1988). Second-order non-linear optical effects in Langmuir-Blodgett films. Thin Solid Films. 160(1-2). 355–362. 13 indexed citations

16.

Jones, Richard J., William E. Beschorner, Victor G. Vogel, et al.. (1987). VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATION. Transplantation. 44(6). 778–783. 673 indexed citations breakdown →

17.

Jones, Richard J., et al.. (1969). Aortic Cholesterol and the Plasma Lipoproteins of the Cholesterol-Fed Cockerel. Experimental Biology and Medicine. 130(1). 163–167. 6 indexed citations

18.

Jones, Richard J., et al.. (1959). THE SERUM LIPID PATTERN IN HYPERTHYROIDISM, HYPOTHYROIDISM, AND CORONARY ATHEROSCLEROSIS. Annals of the New York Academy of Sciences. 72(14). 980–988. 7 indexed citations

19.

Jones, Richard J.. (1956). Serum cholesterol reduction in patients by the oral administration of a brain extract.. PubMed. 47(2). 261–9. 7 indexed citations

20.

Jones, Richard J., et al.. (1956). Chronic Effect of Dietary Protein on Hypercholesteremia in the Rat.. Experimental Biology and Medicine. 93(3). 519–522. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact